Bridgeway Capital Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-300
| Closed | -$27K | – | 1397 |
|
|
2019
Q3 | $27K | Hold |
300
| – | – | ﹤0.01% | 1298 |
|
|
2019
Q2 | $41K | Hold |
300
| – | – | ﹤0.01% | 1284 |
|
|
2019
Q1 | $82K | Buy |
+300
| New | +$82K | ﹤0.01% | 1294 |
|
|
2018
Q4 | – | Sell |
-500
| Closed | -$205K | – | 1480 |
|
|
2018
Q3 | $205K | Buy |
500
+250
| +100% | +$103K | ﹤0.01% | 1318 |
|
|
2018
Q2 | $135K | Buy |
250
+125
| +100% | +$67.5K | ﹤0.01% | 1344 |
|
|
2018
Q1 | $58K | Hold |
125
| – | – | ﹤0.01% | 1351 |
|
|
2017
Q4 | $84K | Sell |
125
-146
| -54% | -$98.1K | ﹤0.01% | 1347 |
|
|
2017
Q3 | $171K | Hold |
271
| – | – | ﹤0.01% | 1300 |
|
|
2017
Q2 | $130K | Hold |
271
| – | – | ﹤0.01% | 1340 |
|
|
2017
Q1 | $203K | Buy |
271
+125
| +86% | +$93.6K | ﹤0.01% | 1278 |
|
|
2016
Q4 | $143K | Sell |
146
-40
| -22% | -$39.2K | ﹤0.01% | 1343 |
|
|
2016
Q3 | $251K | Hold |
186
| – | – | ﹤0.01% | 1277 |
|
|
2016
Q2 | $163K | Hold |
186
| – | – | ﹤0.01% | 1341 |
|
|
2016
Q1 | $260K | Hold |
186
| – | – | ﹤0.01% | 1245 |
|
|
2015
Q4 | $343K | Buy |
186
+39
| +27% | +$71.9K | 0.01% | 1172 |
|
|
2015
Q3 | $287K | Buy |
+147
| New | +$287K | 0.01% | 1230 |
|